Familial defective apolipoprotein B-100: A review

Lars H. Andersen, André R. Miserez, Zahid Ahmad, Rolf L. Andersen

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant genetic disorder of lipid metabolism associated with hyperlipidemia and elevated risk for atherosclerosis. FDB is caused by mutations in APOB reducing the binding affinity between apolipoprotein B-100 and the low-density lipoprotein receptor. Population studies suggest that approximately 0.1% of Northern Europeans and US Caucasians carries the R3500Q variant in APOB most commonly associated with FDB; in addition, the APOB R3500 W variant is known to make a significant contribution to familial hypercholesterolemia (FH) among East Asians. However, the elevation of plasma low-density lipoprotein cholesterol observed in FDB is frequently milder than that of FH due to mutations in LDLR, and FDB is subsequently underdiagnosed according to standard FH diagnostic criteria.

Original languageEnglish (US)
Pages (from-to)1297-1302
Number of pages6
JournalJournal of Clinical Lipidology
Volume10
Issue number6
DOIs
StatePublished - Nov 1 2016

Fingerprint

Hyperlipoproteinemia Type II
Apolipoprotein B-100
Mutation
Inborn Genetic Diseases
LDL Receptors
Hyperlipidemias
Lipid Metabolism
LDL Cholesterol
Atherosclerosis

Keywords

  • APOB
  • Familial defective apolipoprotein B-100
  • Familial hypercholesterolemia
  • FDB
  • FH
  • Hyperlipidemia
  • Lipid metabolism
  • Population genetics
  • R3500Q
  • R3500 W

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics
  • Cardiology and Cardiovascular Medicine

Cite this

Familial defective apolipoprotein B-100 : A review. / Andersen, Lars H.; Miserez, André R.; Ahmad, Zahid; Andersen, Rolf L.

In: Journal of Clinical Lipidology, Vol. 10, No. 6, 01.11.2016, p. 1297-1302.

Research output: Contribution to journalReview article

Andersen, Lars H. ; Miserez, André R. ; Ahmad, Zahid ; Andersen, Rolf L. / Familial defective apolipoprotein B-100 : A review. In: Journal of Clinical Lipidology. 2016 ; Vol. 10, No. 6. pp. 1297-1302.
@article{205201039cc84c4e86ddbe1519610edc,
title = "Familial defective apolipoprotein B-100: A review",
abstract = "Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant genetic disorder of lipid metabolism associated with hyperlipidemia and elevated risk for atherosclerosis. FDB is caused by mutations in APOB reducing the binding affinity between apolipoprotein B-100 and the low-density lipoprotein receptor. Population studies suggest that approximately 0.1{\%} of Northern Europeans and US Caucasians carries the R3500Q variant in APOB most commonly associated with FDB; in addition, the APOB R3500 W variant is known to make a significant contribution to familial hypercholesterolemia (FH) among East Asians. However, the elevation of plasma low-density lipoprotein cholesterol observed in FDB is frequently milder than that of FH due to mutations in LDLR, and FDB is subsequently underdiagnosed according to standard FH diagnostic criteria.",
keywords = "APOB, Familial defective apolipoprotein B-100, Familial hypercholesterolemia, FDB, FH, Hyperlipidemia, Lipid metabolism, Population genetics, R3500Q, R3500 W",
author = "Andersen, {Lars H.} and Miserez, {Andr{\'e} R.} and Zahid Ahmad and Andersen, {Rolf L.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.jacl.2016.09.009",
language = "English (US)",
volume = "10",
pages = "1297--1302",
journal = "Journal of Clinical Lipidology",
issn = "1933-2874",
publisher = "Elsevier BV",
number = "6",

}

TY - JOUR

T1 - Familial defective apolipoprotein B-100

T2 - A review

AU - Andersen, Lars H.

AU - Miserez, André R.

AU - Ahmad, Zahid

AU - Andersen, Rolf L.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant genetic disorder of lipid metabolism associated with hyperlipidemia and elevated risk for atherosclerosis. FDB is caused by mutations in APOB reducing the binding affinity between apolipoprotein B-100 and the low-density lipoprotein receptor. Population studies suggest that approximately 0.1% of Northern Europeans and US Caucasians carries the R3500Q variant in APOB most commonly associated with FDB; in addition, the APOB R3500 W variant is known to make a significant contribution to familial hypercholesterolemia (FH) among East Asians. However, the elevation of plasma low-density lipoprotein cholesterol observed in FDB is frequently milder than that of FH due to mutations in LDLR, and FDB is subsequently underdiagnosed according to standard FH diagnostic criteria.

AB - Familial defective apolipoprotein B-100 (FDB) is an autosomal dominant genetic disorder of lipid metabolism associated with hyperlipidemia and elevated risk for atherosclerosis. FDB is caused by mutations in APOB reducing the binding affinity between apolipoprotein B-100 and the low-density lipoprotein receptor. Population studies suggest that approximately 0.1% of Northern Europeans and US Caucasians carries the R3500Q variant in APOB most commonly associated with FDB; in addition, the APOB R3500 W variant is known to make a significant contribution to familial hypercholesterolemia (FH) among East Asians. However, the elevation of plasma low-density lipoprotein cholesterol observed in FDB is frequently milder than that of FH due to mutations in LDLR, and FDB is subsequently underdiagnosed according to standard FH diagnostic criteria.

KW - APOB

KW - Familial defective apolipoprotein B-100

KW - Familial hypercholesterolemia

KW - FDB

KW - FH

KW - Hyperlipidemia

KW - Lipid metabolism

KW - Population genetics

KW - R3500Q

KW - R3500 W

UR - http://www.scopus.com/inward/record.url?scp=85002141914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002141914&partnerID=8YFLogxK

U2 - 10.1016/j.jacl.2016.09.009

DO - 10.1016/j.jacl.2016.09.009

M3 - Review article

C2 - 27919345

AN - SCOPUS:85002141914

VL - 10

SP - 1297

EP - 1302

JO - Journal of Clinical Lipidology

JF - Journal of Clinical Lipidology

SN - 1933-2874

IS - 6

ER -